Inbiose
Universiteit Gent

Inbiose

Biotech
Biotech
Biotech
Biotech

Inbiose develops a fermentation-based production platform for the supply of specialty carbohydrates addressing wellness, nutrition, AgBio and BioMed needs.

Inbiose was founded mid 2013 as a spin-off from Ghent University. Inbiose develops a versatile fermentation-based production platform for the supply of specialty carbohydrates addressing wellness, nutrition, AgBio and BioMed needs. Specialty carbohydrates are high value added, rare and complex carbohydrates that are extremely hard to produce with conventional technologies (extraction, chemical or enzymatic synthesis). Though these powerful ingredients have been found to be essential for improving health in many areas, applications were hampered until today by the production cost and very limited availability. Inbiose can now tackle these technological issues, giving strong and reliable market perspectives.

No items found.
Marc Zabeau

Marc Zabeau

Managing Partner Qbic I

This company is aligned with the following SDGs

No items found.
Aphea.Bio
Qbic II
Biotech
Biotech
Biotech
Biotech

Aphea.Bio

Aphea.Bio is developing the next generation of agricultural biologicals.

Universiteit Gent
QustomDot
Qbic II
Deeptech
Deeptech
Deeptech
Deeptech

QustomDot

QustomDot is developing cadmium-free quantum dots that are stable enough for advanced applications.

Universiteit Gent
Obulytix
Qbic III
HealthTech
HealthTech
HealthTech
HealthTech

Obulytix

Obulytix develops the next generation of enzyme-based antibiotics inspired by nature.

Universiteit Gent